The recent identifications of a subset of proinflammatory neutrophils, low-density granulocytes, and their ability to readily form neutrophil extracellular traps led to a resurgence of interest in neutrophil dysregulation in the pathogenesis of systemic lupus erythematosus (SLE). This article presents an overview on how neutrophil dysregulation modulates the innate and adaptive immune responses in SLE and their putative roles in disease pathogenesis. The therapeutic potential of targeting this pathogenic process in the treatment of SLE is also discussed.Skewing of type I interferon (IFN) production and responses is a hallmark of systemic lupus erythematosus (SLE). Genetic and environmental contributions to IFN production lead to aberrant innate and adaptive immune activation even before clinical development of disease. Basic and translational research in this arena continues to identify contributions of IFNs to disease pathogenesis, and several promising therapeutic options for targeting of type I IFNs and their signaling pathways are in development for treatment of SLE patients.Professor Eugene Braunwald, often referred to as the 'Father of Modern Cardiology', has contributed significantly to medicine and cardiology. He is best known for the acclaimed textbook Braunwald's Heart Disease and for being the founding chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group. Our primary aim is to highlight his experiences and the guidance that he has to offer to future generations of medical trainees and professionals. An interview with Prof. Braunwald provided the authors with an insight into his journey in medicine. A range of questions were posed pertaining to his struggles and accomplishments in cardiology, his perspectives on the future of cardiology and research, as well as his advice to current and future medical professionals.1 Positive role models are an inspiration to all, regardless of the stage in their career. With hard work, unwavering dedication and a strong desire to make a positive difference to patients and the field, the opportunities are endless. Whether it is clinical or bench research, advances in clinical cardiology and research usually go hand-in-hand. Although primary and secondary prevention of cardiovascular disease remain of critical importance, it is now time to focus on primordial prevention to step back and reduce the development of the risk factors for the future development of cardiovascular disease in the first place. There have been significant advances in cardiology over the past two-thirds of the century during which Prof. Braunwald trained and then led the field. However, there is still much work to be done. Mentors and medical institutions alike must work towards a common goal of 'igniting the fire' within the new generation of clinicians and investigators who will then propel this important specialty to ever greater heights.The term work-life balance may cause physicians to feel inadequate in pursuing a reality in which work and life each have equal importance. Furthermore, the term implies competition between these 2 realms. Instead, work-life integration is a more constructive and realistic term. Achieving harmonious integration requires self-reflection on the current state, goals, and resources and strategies needed to achieve and maintain such a state. Prioritizing aspects of both, and aligning them with individual requirements, while incorporating consistent and intentional investment of time and efforts in both professional and personal arenas is crucial to cultivate and sustain longitudinal well-being.Women lag in leadership roles in many fields, but in academic medicine, and particularly in Otolaryngology, women are even further behind. Understanding personal and cultural biases, changing institutional and systemic practices that perpetuate the challenges, and developing and supporting individual skills will all be necessary to improve the representation of women leaders in academic medicine.Adverse health behaviors are potent drivers of chronic disease and premature mortality. This has led to the development of various lifestyle scores to predict clinical risk, but their complexity makes them impractical for use in clinical settings. PT2385 supplier Thus, there is a need to develop a brief lifestyle score that can assess factors such as exercise and diet within the constraints of routine medical practice. Accordingly, we assessed 19,081 patients undergoing coronary artery calcium (CAC) scanning between September 1, 1998 and December 30, 2016. Each patient completed a questionnaire that included a two-item lifestyle scale regarding patients' frequency of exercise and adherence to a low saturated fat diet. Patients' responses were used to generate a lifestyle score which ranged from very low risk to high risk. Patients were followed for a median of 11.0 years for all-cause mortality. A stepwise relationship was noted between worse lifestyle scores and increased frequency of hypertension, diabetes, smoking, obesity, waist/hip ratio, and resting heart rate and blood pressure. Among patients with zero CAC scores, mortality risk was low regardless of lifestyle score, but as CAC abnormality increased, a stepwise relationship emerged between worse lifestyle scores and mortality. The lifestyle score was more predictive of mortality than conventional CAD risk factors according to multivariable Chi-square analysis. Thus, our results establish the practicality of an ultrashort lifestyle questionnaire that could be employed in nearly all clinical settings. Within our study, our two-item lifestyle scale showed a stepwise relationship to known CAD risk factors and predicted future mortality.Heart failure (HF) commonly progresses over time and identifying differences in volume profiles may help stratify risk and guide therapy. The aim of this study was to assess the pathophysiologic and prognostic roles of volume profiles for HF progression in stable ambulatory and hospitalized patients. HF patients who had undergone quantitative intravascular volume analysis (185 outpatients and 139 inpatients) were retrospectively assessed for the combined end point of HF-related hospital admissions (outpatients), HF-readmissions (inpatients), and overall all-cause mortality. After multivariate Cox regression analysis, greater total blood volume expansion was associated with higher risk of HF-admission in previously stable outpatients (HR 1.023, CI 1.005 to 1.043; p = 0.013) while in more advanced HF (inpatients) total blood volume expansion was associated with lower risk for HF-readmission and mortality (HR 0.982, CI 0.967 to 0.997; p = 0.017). Secondary analysis suggests that subclinical plasma volume expansion was a driving factor for the detrimental association in outpatients (HR 1.